Clinical Trial: IAP-086-1: A Phase 1 Single Ascending Dose First-Time in Human Study

U.S., May 20 -- ClinicalTrials.gov registry received information related to the study (NCT07596888) titled 'IAP-086-1: A Phase 1 Single Ascending Dose First-Time in Human Study' on May 12.

Brief Summary: Purpose: To assess the safety and tolerability of a single dose of IAP086 in persons with HIV suppressed on stable ART Participants: 30 people from UNC within 18 to 70years of age. People with HIV on ART with plasma HIV-1 RNA < 50 copies/mL for 12 months prior to screening.

Procedures (methods):

The participant's standard of care ART regimen is continued throughout the study period.

This study requires an overnight stay in a research unit. During the overnight stay, participants will receive a single infusion (medicine given slowly thro...